Entering text into the input field will update the search result below

Esperion Therapeutics, Inc. (ESPR) CEO Sheldon Koenig on Q1 2022 Results - Earnings Call Transcript

May 03, 2022 2:08 PM ETEsperion Therapeutics, Inc. (ESPR)
SA Transcripts profile picture
SA Transcripts

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2022 Earnings Conference Call May 3, 2022 8:00 AM ET

Company Participants

Tiffany Aldrich - Senior Manager, Corporate Communications

Sheldon Koenig - President and Chief Executive Officer

Joanne Foody - Chief Medical Officer

Eric Warren - Chief Commercial Officer

BJ Swartz - Chief Strategy Officer

Conference Call Participants

Serge Belanger - Needham

Jason Butler - JMP Securities

Jessica Fye - JPMorgan

Jeff Hung - Morgan Stanley

Joseph Thome - Cowen

Paul Choi - Goldman Sachs

Emanuela Branchetti - H.C. Wainwright

Judah Frommer - Credit Suisse


Ladies and gentlemen, thank you for standing by and welcome. [Operator Instructions] Please be advised that today’s conference call may be recorded. I would now like to hand the conference over to Tiffany Aldrich, Senior Manager in Corporate Communications at Esperion. Please go ahead.

Tiffany Aldrich

Thank you. Good morning and welcome to Esperion’s first quarter 2022 financial results and company update conference call. I am Tiffany Aldrich and I’m part of the Corporate Communications team here at Esperion.

I want to remind callers that the information discussed on the call today is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. I caution listeners that management will be making forward-looking statements. Actual results could differ materially from those stated or implied by our forward-looking statements due to risks and uncertainties associated with the business. These forward-looking statements are qualified in their entirety by the cautionary statements contained in today’s press release and our SEC filings.

The content of this conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, May 3, 2022. We undertake no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call and webcast. As a reminder, this conference

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.